PROSTATIC HYPERPLASIA; COMPARISON BETWEEN TAMSULOSIN AND TERAZOSIN FOR EFFICACY IN MEDICAL MANAGEMENT OF LOWER URINARY TRACT SYMPTOMS SECONDARY TO PROSTATIC HYPERPLASIA

Benign prostatic hyperplasia and lower urinary tract symptoms: research priorities.

Department of Urology, Sant’Andrea Hospital, University ‘‘La Sapienza,’’ Rome, Italy; Department of Urology, University Medical Centre HamburgEppendorf, Hamburg, Germany; Urology Clinic, Second University of Naples, Naples, Italy; Universitätsspital Basel, Urologische Klinik, Basel, Switzerland; Department of Urology, University Hospital of Lublin, Lublin, Poland; Department of Urology, Vita-Sa...

Tamsulosin versus terazosin for benign prostatic hyperplasia: a systematic review.

The effectiveness and safety of tamsulosin and terazosin for patients with benign prostatic hyperplasia (BPH) was evaluated by literature review. PubMed, Embase, the Cochrane Library, Chinese biomedicine literature database (CBM), reference lists of reports, and reviews were searched for randomized controlled trials (RCTs), or quasi-RCTs of tamsulosin versus terazosin in BPH. Twelve studies inv...

Phosphodiesterase 5 inhibitors for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review.

OBJECTIVE • To review the evidence in support of the effectiveness of phosphodiesterase 5 inhibitors in lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH). METHODS • Relevant studies were identified by performing a literature search using MEDLINE® and The Cochrane Library®. The criteria used during the search included randomized, placebo-controlled trials of trea...

New medical treatments for lower urinary tract symptoms due to benign prostatic hyperplasia and future perspectives

BACKGROUND Lower Urinary Tract Symptoms (LUTS) in men are a common clinical problem in urology and have been historically strictly linked to benign prostatic hyperplasia (BPH), which may lead to bladder outlet obstruction (BOO). New molecules have been approved and have entered the urologists' armamentarium, targeting new signaling pathways and tackling specific aspects of LUTS. Objective of th...

Treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.